Global Genes Launches RARE Patient Identification and Inclusion Initiative to Address Critical Gaps in Diagnosis, Research and Trials for Rare Neurological Conditions

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes, a leading international rare disease advocacy organization, today announced the launch of a Patient Identification and Engagement for RARE CNS Disorders (PIE4CNS) multi-stakeholder initiative. The PIE4CNS initiative will address major gaps in the timely and comprehensive diagnosis of rare central nervous system (CNS) related conditions,...

Click to view original post